(Reuters) – The U.S. Food and Drug Administration approved Pfizer Inc’s drug Cibinqo to treat eczema, a skin disease, the company said on Friday.
(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
Phillies hold on to beat Giants in Series Opener
Mitchell scores 50 points in an attempt to end series, but Cavaliers fall to the Magic in Game 6
Arsenal keeps up Premier League title push with 3-0 win over Bournemouth
Tyronn Lue says he wants to keep coaching Clippers, passes on addressing speculation over Lakers
IOC imposes 15-year ban on former Olympic power broker Sheikh Ahmad of Kuwait
Russia puts Ukrainian President Zelenskyy on its wanted list
Senate races are roiled by campus protests over the war in Gaza as campaign rhetoric sharpens
There’s progress reported in Gaza truce talks, but Israel downplays chances of ending war with Hamas
Modern campus protests: echoes of the past, but smaller and quieter for now
City Council seeks probe into NYPD brass’ ‘intimidating and dangerous’ social media activity
As the US moves to reclassify marijuana as a less dangerous drug, could more states legalize it?
Aetna agrees to settle lawsuit over fertility coverage for LGBTQ+ customers
A senior UN official says northern Gaza is now in ‘full-blown famine’
Mississippi Republicans revive bill to regulate transgender bathroom use in schools
